Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 55
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Immunonutrition, Gastrostomy Trial in Taipei (oral glutamine, Maltodextrin)

Recruiting
  • Gastric Cancer
  • +2 more
  • oral glutamine
  • Maltodextrin
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 6, 2023

Gastric Cancer Trial in Taiwan (AST-301, rhuGM-CSF)

Not yet recruiting
  • Gastric Cancer
  • Kaohsiung, Taiwan
  • +5 more
Mar 14, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Phoenix, Arizona
  • +119 more
Feb 1, 2023

Gastric Cancer Trial in Worldwide (AZD2936, MEDI5752, FOLFOX)

Recruiting
  • Gastric Cancer
  • Beijing, China
  • +25 more
Jan 18, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma Trial in Worldwide (Evorpacept (ALX148),

Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +54 more
Jan 23, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, Korea, Republic of, Taiwan (Bemarituzumab, CAPOX, SOX)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Northport, New York
  • +13 more
Jan 4, 2023

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (Pembrolizumab, Placebo, Cisplatin)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Pembrolizumab
  • +7 more
  • Duarte, California
  • +170 more
Aug 18, 2022

Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus

Recruiting
  • Mesothelioma
  • +14 more
  • Los Angeles, California
  • +13 more
Aug 16, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Gastric Cancer, GastroEsophageal Cancer Trial in Worldwide (Bavituximab, Pembrolizumab Injection)

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • New Haven, Connecticut
  • +20 more
Jun 14, 2022

Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Ipilimumab, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Kashiwa-shi, Chiba, Japan
  • +56 more
Jun 1, 2022

Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)

Recruiting
  • Gastric Cancer
  • +3 more
  • leucovorin, oxaliplatin, docetaxel, S-1
  • Kaohsiung, Taiwan
  • +3 more
May 24, 2022

Gastric Cancer Trial in Worldwide (Nivolumab, Tegafur-gimeracil-oteracil potassium, Oxaliplatin)

Active, not recruiting
  • Gastric Cancer
  • Anhui Province, China
  • +107 more
May 22, 2022

Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus

Terminated
  • Advanced Gastrointestinal (GI) Malignancies
  • +3 more
  • ADI-PEG 20 plus modified FOLFOX6
  • San Francisco, California
  • +34 more
Apr 18, 2022

Gastric Cancer Trial in Japan, Korea, Republic of, Taiwan (ONO-4538, Oxaliplatin, Tegafur- Gimeracil-Oteracil potassium)

Active, not recruiting
  • Gastric Cancer
  • Nagoya, Aichi, Japan
  • +129 more
Apr 20, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Cancer Trial in China, Korea, Republic of, Taiwan (ZW25, Docetaxel,

Active, not recruiting
  • Breast Cancer
  • +2 more
  • ZW25
  • +4 more
  • Beijing, Beijing, China
  • +21 more
Apr 1, 2022

Gastric Cancer Trial in Worldwide (5-Fluorouracil, Ipatasertib, Leucovorin)

Completed
Has Results
  • Gastric Cancer
  • Los Angeles, California
  • +33 more
Feb 18, 2022

Gastric Cancer, Esophageal Cancer, Gastro-esophageal Cancer Trial in Taiwan, United States (Oraxol, Ramucirumab)

Unknown status
  • Gastric Cancer
  • +2 more
  • San Antonio, Texas
  • +4 more
Feb 15, 2022

Gastric Cancer Trial in Worldwide (Varlitinib, mFOLFOX6, Placebo)

Completed
  • Gastric Cancer
  • Tallinn, Estonia
  • +15 more
Feb 14, 2022

Gastric Cancer, Peritoneal Carcinomatosis Trial in Taipei (CRS followed by IP and systemic chemotherapies)

Recruiting
  • Gastric Cancer
  • Peritoneal Carcinomatosis
  • CRS followed by IP and systemic chemotherapies
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 19, 2022

Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

Active, not recruiting
  • Cholangiocarcinoma
  • +5 more
  • Gilbert, Arizona
  • +57 more
Jan 5, 2022